
Advertise on podcast: CReATe Podcast
Rating
5from
This podcast has
89 episodes
Language
EnglishPublisher
CReATe ConsortiumExplicit
No
Date created
2018/03/07
Latest episode
2026/09/22
Average duration
22 min.
Release period
37 days
Description
CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.
Unlock CReATe Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from CReATe Podcast podcast
CReATe Author Series Ep. 20 - Dr. Michael Benatar and Proteomics of Pre-symptomatic ALS
2026/09/22
Dr. Michael Benatar is a professor of neurology and chief of the Neuromuscular Division and executive director of the ALS Center at the University of Miami. Here he discusses the recent publication “Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS".
ALS Untangled Series Ep. 68 - Pyridostigmine
2026/09/03
Pyridostigmine enhances neuromuscular transmission and is commonly used to treat myasthenia gravis. The effect of pyridostigmine in slowing ALS progression is uncertain. Here we discuss the potential mechanisms, cases, clinical trial data, and potential risks.
ALS Untangled Series Ep. 67 - Alpha Lipoic Acid
2026/08/07
Alpha-lipoic acid (ALA) is a naturally occurring fatty acid. It has several plausible mechanisms for slowing ALS progression. Preclinical studies showed ALA slowed motor function decline. Some patients reported improvement when taking ALA together with other supplements. Here we discuss the mechanism, clinical studies, and potential risks.
CReATe Author Series Ep. 19 - Dr. Paul Lingor on Fasudil as a Potential Therapeutic for ALS
2026/07/01
Paul Lingor, MD, is Professor for Neurology, Group Leader and Head of the Outpatient Clinics for Motoneuron Disorders and Co-head of the Outpatient Clinics for Movement Disorders and at the Department of Neurology of the TUM Klinikum Rechts der Isar in Munich, Germany. Here he discusses the recent publication "Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial."
ALS Untangled Series Ep. 66 - PoNS
2026/06/03
Portable Neuromodulation Stimulator (PoNS) is a type of electrical stimulation that can theoretically increase rewiring in the brain (neuroplasticity). Small trials suggest that it can improve walking in MS but thus far there are no data in people living with ALS. Here we further discuss the mechanism, studies in other conditions, and potential risks.
ALS Untangled Series Ep. 65 - ISRIB
2026/05/15
ISRIB stands for “integrated stress response inhibitor). As we discuss here, it is an oral medication that inhibits an intracellular pathway called the integrative stress response pathway. It is not FDA approved for any condition but is available in Spain without a prescription. There are theoretical ways that inhibiting this pathway could help a person with ALS, and there is promising data from preclinical ALS models. However, it is not clear that ISRIB is soluble enough to get into motor neurons in the brain and spinal cord, and 2 of 3 trials of agents targeting the same pathway failed to show any benefits in people with ALS. The risks of this product in ALS are not known.
CReATe Author Series Ep. 18 - Dr. Michael Benatar on MMI as a prodromal stage of ALS
2026/04/09
Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “Proposed Research Criteria for Mild Motor Impairment as a Prodromal Syndrome in Amyotrophic Lateral Sclerosis."
CReATe Author Series Ep. 17 - (AI generated) Podcast on C9orf72 Disease Prevention Trials
2026/01/08
Here we have a podcast produced by artificial intelligence discussing the recent publication “Design considerations for C9orf72 disease prevention trials”.
ALS Untangled Series Ep. 64 - Wahls Protocol
2025/12/10
The Wahls Protocol is a diet that may reduce inflammation, oxidative stress, and mitochondrial dysfunction. Although these are plausible mechanisms for slowing ALS progression, we discuss the fact that there are no actual data to support this hypothesis, and there are risks which are especially important to consider in people living with ALS.
ALS Untangled Series Ep. 63 - Psilocybin
2025/11/17
Psilocybin is a psychedelic chemical derived from mushrooms. It is under study for mood problems in people with ALS. Here we review its plausible mechanisms for slowing ALS progression. But there are no data from preclinical models, trials or case reports that currently support this benefit. And there can be serious risks to using this chemical.
ALS Untangled Series Ep. 62 - Ashwagandha
2025/10/20
Here we review ashwagandha a nutritional supplement that has plausible mechanisms for slowing ALS, promising pre-clinical evidence, and a reasonable safety profile. There is one person with ALS who experienced a reversal of symptoms on a cocktail of treatments that included ashwagandha. Cases like this are difficult to interpret as there can be multiple explanations for a person experiencing an ALS reversal. We have not found any other cases suggesting improvement on this product. We hope to see the data from the completed phase 2 trial soon.
CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS
2025/09/24
Dr. Johnathan Cooper-Knock is a neurologist and clinical lecturer at the University of Sheffield. His research focuses on genetic causes of ALS. Here he discusses his recent publication “Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis”.
ALS Untangled Series Ep. 61 - Zinc
2025/09/09
Here we review Zinc supplements as a treatment for ALS. These are inexpensive, reasonably safe at certain doses, and are easy to acquire. They have plausible mechanisms by which they could slow ALS progression. However, the data from people living with ALS is not very convincing yet.
CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers
2025/06/02
Dr. Terry Heiman-Patterson is a neurologist and professor at Temple University and the director of the Center for Neurodegenerative Disorders and the MDA/ALS Center of Hope. Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. In this podcast they will be discussing their recent publication “Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD”.
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS
2025/05/01
Dr. Ruben van Eijk is an associate professor in the Department of Neurology at the University Medical Center Utrecht in the Netherlands as well as a statistical consultant and medical statistician for the clinical trial methodology group at the Julius Center also in Utrecht. Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “Rethinking phase 2 trials in amyotrophic lateral sclerosis”.
Podcast reviews
Read CReATe Podcast podcast reviews
BeckyfromIowa 2021/10/05
So helpful!
This podcast is so helpful for pALS and caregivers pursuing alternative treatments. I did my doctoral work in genetics, but have no experience in hum...
Podcast sponsorship advertising
Start advertising on CReATe Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.920911196
Toni and Ryan
Toni Lodge and Ryan Jon

4.6652752197
The Charlie Kirk Show
Charlie Kirk

4.723181990
Timeless Wisdom with Dennis Prager
Salem Podcast Network

4.861541133
The David Pakman Show
David Pakman

4.8167482000
The GaryVee Audio Experience
Gary Vaynerchuk

4.827591720
Earn Your Happy
Lori Harder | YAP Media

4.762632000
The Lawfare Podcast
The Lawfare Institute

4.715161997
Thrivetime Show | Business School without the BS
Clay Clark

4.98711800
The Adam Mockler Show
MeidasTouch Network

4.824781901
Deck The Hallmark
Bramble Jam Podcast Network